Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Sweet Sugar based Beverages Cause Non-Alcoholic Fatty Liver, Other Chronic Diseases
A study revealed that Drinking sugar-sweetened beverages daily may increase the risk of Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic fatty liver disease (NAFLD) is the build up of extra fat in liver cells that is not caused by alcohol. It is normal for the liver to contain some fat. However, if more than 5% - 10% percent of the liver’s weight is fat, then it is called a fatty liver (steatosis).Sugar-sweetened beverages are a major dietary source of fructose, the sugar which is suspected of increasing risk of NAFLD because of how our bodies process it. The study appeared in the Journal of Hepatology.
- Read more about Romaco will debut anti-counterfeit solution for blister packs
Romaco Group, a leading global supplier of processing and packaging equipment, will be present the first ever anti-counterfeit solution for blister packs at ACHEMA, Frankfurt/Main (Germany), from June 15 to 19, 2015. The new system was developed exclusively with its partner company NANO 4 U. The system can be incorporated into all blister machines equipped with coding stations and will be showcased at Achema in a Romaco Noack line 960. The blisters feature a NANO4U hologram stamp which can incorporate a hidden logo or code, as well as other covert and overt safety features.
- Read more about Nerve Pain Therapy by Botulinum Toxin
A new study said that Botulinum toxin, commonly known as Botox could offer an effective new treatment for two forms of neuropathy, pain caused by different types of nerve injury. The study appeared in Anesthesia & Analgesia.
- Read more about Multiplicom launch new kits to monitor hereditary breast & ovarian cancers
Multiplicom N.V., develops, manufactures and commercializes molecular diagnostic assays, launched two kits-- the BRCA Hereditary Cancer MASTR Plus kit and the BRCA Tumor MASTR Plus kit, to screen hereditary breast and ovarian cancers. The BRCA Hereditary Cancer MASTR kit detects germline variants in 26 genes associated with hereditary cancers and the BRCA Tumor MASTR Plus is used for detection of variants in BRCA1 and BRCA2 in tumour biopsy material.
- Read more about Vasculotide drug Effective Against Multiple Strains of Influenza Including Swine Flu
Scientists found the drug was effective in two different strains of mice and three different strains of flu believe the drug could be effective in animals other than mice, including humans. Scientists in Canada developed a new drug that are effective against flu virus.People who die from the flu actually die from respiratory failure, when the lung's tiny blood vessels start leaking fluid into the lung's air sacs. Instead of targeting the virus that causes flu, the new drug can prevent the blood vessels from leaking fluid into the lung's air sacs.
- Read more about US FDA grants MediciNova's MN-166 to Orphan Drug status to treat Krabbe disease
The US Food and Drug Administration (FDA) has granted orphan-drug designation to biopharmaceutical company MediciNova Inc.'s MN-166 (ibudilast) for treatment of Krabbe disease. MediciNova previously opened an Investigational New Drug (IND) application with the Division of Neurology Products (DNP) for MN-166 (ibudilast).
- Read more about ILife Discoveries develop gene test to asess cancer recurrence risk
ILife Discoveries, genetics and genomics company has introduced a new gene test in India. This will help oncologists get a deeper insight into tumors. The new MammaPrint & Blueprint test is able to analyse molecular subtypes of the cancer, risk of recurrence of early stage cancer, thereby enabling medical oncologists to take informed decisions on the course of treatment. For millions of breast cancer patients in India, the twin technologies are advancements that can shed new light on whether treatment is possible without undergoing the harsh chemotherapy process.
- Read more about During Pregnancy Antiviral Drug Telbivudine Prevents Transmission of Hepatitis B Virus
Hepatitis B virus is a leading cause of liver disease. Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus. It is a major global health problem. A new study has found that an antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV). The study is published in Clinical Gastroenterology and Hepatology.

[adsense:336x280:8701650588]
- Read more about Pharmatech, InQui collaborate to boost development of life science cos
Pharmatech Associates and InQui Capital of Hong Kong announced the Pharmatech Connect programme, a collaboration bringing development opportunities to early stage life science technology companies in the areas of investments, market expansion and strategic alliances worldwide.
- Read more about Cipla receive US FDA approval for Lopinavir, Ritonavir oral pellets to treat AIDS in infants
The US FDA has granted approval to Cipla's Lopinavir, Ritonavir (LPV/r) 40mg/ 10 mg oral pellets for paediatric specific treatment of HIV in infants. Cipla was working for many years in collaboration with Diana Gibb, professor of epidemiology, senior programme leader and honorary consultant paediatrician at Medical Research Council Clinical Trials Unit at UCL (University College London) towards development of this novel child-friendly formulation which has been approved by US FDA under the President’s Emergency Plan for AIDS Relief (PEPFAR) programme. This product is a first step in making accessible more modern and appropriately formulated treatment available to the most vulnerable of HIV patients – young children.